BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01962896-completion@plaintrial.com
DTSTAMP:20261028T013550Z
DTSTART;VALUE=DATE:20180127
SUMMARY:A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory
  Germ Cell Tumors — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT01962896
URL:https://plaintrial.com/trial/NCT01962896
END:VEVENT
END:VCALENDAR